NantHealth Rolls Out NaviNet AllPayer Platform Nationally
September 22 2020 - 9:15AM
Business Wire
Expansion gives providers a fast and intuitive
solution with comprehensive health plan access
NantHealth, Inc. (NASDAQ: NH), a next-generation,
evidence-based, personalized healthcare company, announced the
national rollout of NaviNet AllPayer, a subscription-based platform
allowing providers increased visibility into standard eligibility
and benefit information for over 1,000 commercial and government
health plans using a single login. Providers can also check claim
status for over 550 health plans. AllPayer eliminates the need to
sign-in to multiple portals, helps cut down wait times for prior
authorizations, and eliminates long-term contracts by offering
month-to-month service. Providers can access the AllPayer platform
as members of NaviNet Open.
Building upon the existing multi-payer experience of NaviNet
Open, NaviNet AllPayer expands the breadth of the health plan
reach, increases efficiency by eliminating the need to jump between
portals or to spend time on the phone in search of information, and
facilitates ease of use by allowing for the option to cancel,
upgrade or downgrade at any time. In addition, the intuitive
navigation and seamless integration into existing workflows further
confirm the full-service nature of the platform.
“The national expansion of NaviNet AllPayer broadens health care
provider access to over 1,000 commercial and state Medicaid plans;
a significant increase from the 47 sponsored health plans we
currently offer from NaviNet,” said Ron Louks, Chief Operating
Officer, NantHealth. “NaviNet AllPayer is our solution for creating
the most uniform and user-friendly experience for healthcare
organizations everywhere.”
NaviNet AllPayer improves communication and increases
collaboration across a secure, easy-to-use system for exchanging
vital data in real-time.
About NantHealth, Inc.
NantHealth, a member of the NantWorks ecosystem of companies,
provides leading solutions across the continuum of care for
physicians, payers, patients and biopharmaceutical organizations.
NantHealth enables the use of cutting-edge data and technology
toward the goals of empowering clinical decision support and
improving patient outcomes. NantHealth’s comprehensive product
portfolio combines the latest technology in payer/provider
platforms that exchange information in near-real time (NaviNet and
Eviti), and molecular profiling services that combine comprehensive
DNA & RNA tumor-normal profiling with pharmacogenomics analysis
(GPS Cancer®). For more information, please visit nanthealth.com or
follow us on Twitter, Facebook and LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200922005045/en/
NantHealth Jen Hodson Jen@nant.com 562-397-3639
NantHealth (NASDAQ:NH)
Historical Stock Chart
From Aug 2024 to Sep 2024
NantHealth (NASDAQ:NH)
Historical Stock Chart
From Sep 2023 to Sep 2024